ReviewCancer science2026

MAPK Inhibitor-Tolerant Persister Cells in Melanoma: Mechanisms and Therapeutic Vulnerabilities.

Bhoomi Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.